Patients most likely to benefit from PANXEON screening include individuals with inherited genetic risk, a family history of pancreatic cancer, pancreatic cysts, or chronic pancreatitis.

Health news, debates, and claims covering public health, mental health, nutrition, medical care, and health policy.

Cancer treatment, oncology drug access, hematologic malignancies, and cancer drug policy.

Specific solid tumor cancer types organized by organ system and tissue origin.

Cancer prevention strategies, screening, early detection, and diagnostic approaches.